company background image
HAEK

HAEMATO XTRA:HAEK Stock Report

Last Price

€20.60

Market Cap

€106.6m

7D

4.6%

1Y

-3.7%

Updated

29 May, 2023

Data

Company Financials +

HAEK Stock Overview

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany.

HAEK fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

HAEMATO AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for HAEMATO
Historical stock prices
Current Share Price€20.60
52 Week High€22.60
52 Week Low€13.65
Beta1.3
1 Month Change13.19%
3 Month Change-3.74%
1 Year Change-3.74%
3 Year Change-3.74%
5 Year Change-65.08%
Change since IPO-49.76%

Recent News & Updates

HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20

May 20
HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20

We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)

May 12
We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)

HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher

Dec 08
HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher

Recent updates

HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20

May 20
HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20

We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)

May 12
We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)

HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher

Dec 08
HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher

The Strong Earnings Posted By HAEMATO (ETR:HAEK) Are A Good Indication Of The Strength Of The Business

May 24
The Strong Earnings Posted By HAEMATO (ETR:HAEK) Are A Good Indication Of The Strength Of The Business

HAEMATO (ETR:HAEK) Hasn't Managed To Accelerate Its Returns

Nov 17
HAEMATO (ETR:HAEK) Hasn't Managed To Accelerate Its Returns

HAEMATO (ETR:HAEK) Will Be Hoping To Turn Its Returns On Capital Around

May 30
HAEMATO (ETR:HAEK) Will Be Hoping To Turn Its Returns On Capital Around

We're Not Very Worried About HAEMATO's (ETR:HAEK) Cash Burn Rate

Mar 08
We're Not Very Worried About HAEMATO's (ETR:HAEK) Cash Burn Rate

What Do The Returns At HAEMATO (ETR:HAEK) Mean Going Forward?

Feb 15
What Do The Returns At HAEMATO (ETR:HAEK) Mean Going Forward?

Estimating The Fair Value Of HAEMATO AG (ETR:HAEK)

Jan 25
Estimating The Fair Value Of HAEMATO AG (ETR:HAEK)

Is Now An Opportune Moment To Examine HAEMATO AG (ETR:HAEK)?

Jan 04
Is Now An Opportune Moment To Examine HAEMATO AG (ETR:HAEK)?

Reflecting on HAEMATO's (ETR:HAEK) Share Price Returns Over The Last Three Years

Dec 14
Reflecting on HAEMATO's (ETR:HAEK) Share Price Returns Over The Last Three Years

Shareholder Returns

HAEKDE HealthcareDE Market
7D4.6%-2.5%-1.3%
1Y-3.7%-21.5%-8.5%

Return vs Industry: HAEK exceeded the German Healthcare industry which returned -22.1% over the past year.

Return vs Market: HAEK exceeded the German Market which returned -8.1% over the past year.

Price Volatility

Is HAEK's price volatile compared to industry and market?
HAEK volatility
HAEK Average Weekly Movement4.8%
Healthcare Industry Average Movement4.3%
Market Average Movement5.0%
10% most volatile stocks in DE Market9.9%
10% least volatile stocks in DE Market2.7%

Stable Share Price: HAEK is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: HAEK's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199376Patrick Brenskehttps://www.haemato.ag

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products.

HAEMATO AG Fundamentals Summary

How do HAEMATO's earnings and revenue compare to its market cap?
HAEK fundamental statistics
Market Cap€106.64m
Earnings (TTM)€8.19m
Revenue (TTM)€249.07m

13.1x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HAEK income statement (TTM)
Revenue€249.07m
Cost of Revenue€226.53m
Gross Profit€22.54m
Other Expenses€14.35m
Earnings€8.19m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

May 31, 2023

Earnings per share (EPS)1.57
Gross Margin9.05%
Net Profit Margin3.29%
Debt/Equity Ratio0%

How did HAEK perform over the long term?

See historical performance and comparison

Dividends

5.3%

Current Dividend Yield

816%

Payout Ratio

Does HAEK pay a reliable dividends?

See HAEK dividend history and benchmarks
When do you need to buy HAEK by to receive an upcoming dividend?
HAEMATO dividend dates
Ex Dividend DateJul 19 2023
Dividend Pay DateJul 21 2023
Days until Ex dividend49 days
Days until Dividend pay date51 days

Does HAEK pay a reliable dividends?

See HAEK dividend history and benchmarks